Journal ArticlePLoS One · 2025
OBJECTIVE: Acupuncture is an evidence-based pain treatment in clinic settings, but its optimal delivery has not been established in emergency departments (EDs). As part of an adaptive pragmatic randomized controlled trial of ED acupuncture for acute muscul ...
Full textLink to itemCite
Journal ArticleAnn Emerg Med · October 2024
STUDY OBJECTIVE: Acute musculoskeletal pain in emergency department (ED) patients is frequently severe and challenging to treat with medications alone. The purpose of this study was to determine the feasibility, acceptability, and effectiveness of adding E ...
Full textLink to itemCite
Journal ArticleOrphanet J Rare Dis · November 10, 2023
BACKGROUND: Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multisystemic, life-threatening disease resulting from the deposition of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in various tissues and organs. METHO ...
Full textOpen AccessLink to itemCite
Journal ArticleBMJ Open · September 23, 2022
INTRODUCTION: Chronic musculoskeletal pain causes a significant burden on health and quality of life and may result from inadequate treatment of acute musculoskeletal pain. The emergency department (ED) represents a novel setting in which to test non-pharm ...
Full textLink to itemCite
Journal ArticleHepatol Commun · February 2022
Exercise is a foundational treatment for nonalcoholic fatty liver disease (NAFLD); however, the majority of patients are unable to initiate and maintain effective exercise habits and remain at increased risk for progressive liver disease. Barriers and limi ...
Full textLink to itemCite
Journal ArticleComplement Ther Clin Pract · November 2021
BACKGROUND & PURPOSE: The COVID-19 pandemic has negatively impacted mental health in the general population. In this trial, our objective was to assess whether a 6-week expressive writing intervention improves resilience in a sample from the general popula ...
Full textLink to itemCite
Journal ArticleJournal of hepatology · September 2020
Lifestyle modification is the foundation of treatment recommendations for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The design of clinical trials in NASH may be impeded by the lack of a systematic approach to ident ...
Full textCite
Journal ArticleJournal of general internal medicine · March 2019
BackgroundCurrent treatment options for knee osteoarthritis have limited effectiveness and potentially adverse side effects. Massage may offer a safe and effective complement to the management of knee osteoarthritis.ObjectiveExamine effec ...
Full textCite
Journal ArticleComplement Ther Clin Pract · February 2019
BACKGROUND AND PURPOSE: Trauma is highly prevalent, with estimates that up to 90% of the U.S. population have been exposed to a traumatic event. The adverse health consequences of trauma exposure are diverse and often long-lasting. While expressive writing ...
Full textLink to itemCite
Journal ArticleHepatol Commun · November 2018
The severity of hepatic fibrosis is the primary predictor of liver-related morbidity and mortality in patients with nonalcoholic fatty liver disease (NAFLD). Unfortunately, noninvasive serum biomarkers for NAFLD-associated fibrosis are limited. We analyzed ...
Full textLink to itemCite
Journal ArticleJournal of Functional Morphology and Kinesiology · December 1, 2017
Nonalcoholic Fatty Liver Disease (NAFLD) is a growing health epidemic in developed countries with increased prevalence in obese and diabetic populations. Exercise is an established and essential component of lifestyle modification for NAFLD disease managem ...
Full textCite
Journal ArticleOncotarget · November 24, 2017
Exposure to exercise following a breast cancer diagnosis is associated with reductions in the risk of recurrence. However, it is not known whether breast cancers within the same molecular-intrinsic subtype respond differently to exercise. Syngeneic mouse m ...
Full textOpen AccessLink to itemCite
Journal ArticleClin Adv Hematol Oncol · June 2016
The use of targeted therapies in patients with genitourinary malignancies has significantly improved outcomes. For example, androgen receptor (AR) pathway inhibitors have improved outcomes for patients with prostate cancer, and antiangiogenic agents have i ...
Link to itemCite
Journal ArticleBr J Cancer · March 3, 2015
BACKGROUND: Few studies have investigated the effects of exercise on modulation of host factors in cancer patients. We investigated the efficacy of chronic aerobic training on multiple host-related effector pathways in patients with solid tumours. PATIENTS ...
Full textLink to itemCite
ConferenceCancer Research · April 15, 2013
AbstractIt is becoming increasingly recognized that host (systemic) and tumor cell release of proinflammatory growth factors are critical determinants of cancer progression and therapeutic response in patien ...
Full textCite
Journal ArticleVaccine · November 21, 2011
While many tumor associated antigens (TAAs) have been identified in human cancers, efforts to develop efficient TAA "cancer vaccines" using classical vaccine approaches have been largely ineffective. Recently, a process to specifically target proteins to e ...
Full textLink to itemCite
Journal ArticleCancer Res · July 1, 2011
HER2 overexpression occurs in approximately 25% of breast cancers, where it correlates with poor prognosis. Likewise, systemic inflammation in breast cancer correlates with poor prognosis, although the process is not understood. In this study, we explored ...
Full textLink to itemCite
Journal ArticleCancer Res · September 15, 2010
Although critical for initiating and regulating immune responses, the therapeutic use of individual cytokines as anticancer immunotherapeutic agents has achieved only modest clinical success. Consequently, many current strategies have focused on the use of ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 1, 2010
PURPOSE: Overexpression of the breast cancer oncogene HER2 correlates with poor survival. Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease. Because refractory tumors remain strongly HER2+, va ...
Full textLink to itemCite
Journal ArticleCancer Gene Ther · September 2009
Recombinant serotype 5 adenovirus (Ad5) vectors lacking E1 expression induce robust immune responses against encoded transgenes in pre-clinical models, but have muted responses in human trials because of widespread pre-existing anti-adenovirus immunity. At ...
Full textLink to itemCite
Journal ArticleVirology · May 10, 2008
Human Adenovirus Type 4 (HAdV-4) is responsible for epidemic outbreaks of Acute Respiratory Disease (especially in military recruits), and is known to cause significant morbidity with several reported cases of mortality. However, we do not understand why t ...
Full textLink to itemCite